Search

Search Constraints

You searched for: Author/Creator Thaler, Josef

Search Results

1. A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1. Issue 5 (19th August 2020)

2. A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1. Issue 5 (4th May 2018)

3. Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications. Issue 1 (December 2016)

5. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018)

6. Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia. (1st June 2021)

7. Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study. (July 2020)

8. Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg‐proline‐interferon alpha‐2b. Issue 4 (2nd March 2015)

9. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX. (September 2017)

10. Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial. (10th November 2018)